福懋 1434
Listed · Textiles17.4▼-0.2 (-1.14%)After close
- Prev close
- 17.6
- Volume (shares)
- 2,100,773
- Data time
- 2026-11-11 13:30:00
- Open
- 17.45
- High
- 17.60
- Low
- 17.20
- Prev close
- 17.60
- Volume (lots)
- 2,101
- Turnover
- 0.36 億
- P/E
- 20.0
- Cash yield
- 2.87%
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 8.78% | 10.95% | 11.18% | 10.73% | 11.27% | 11.42% | 11.26% | 10.69% |
| Operating margin | -1.44% | 1.98% | 2.85% | 1.58% | 1.43% | 3.85% | 3.55% | 2.29% |
| Net margin | 3.93% | 6.97% | 4.82% | 6.24% | 5.10% | -0.48% | 2.43% | 1.55% |
| ROE (TTM) | 2.83% | 3.73% | 2.47% | 2.18% | 1.45% | 2.94% | 3.44% | 3.27% |
| ROA (TTM) | 2.21% | 2.70% | 1.77% | 1.58% | 1.05% | 2.09% | 2.46% | 2.40% |
| EPS, quarter (TWD) | 0.14 | 0.30 | 0.20 | 0.22 | 0.20 | -0.02 | 0.11 | 0.07 |
| EPS, TTM (TWD) | 0.86 | 0.92 | 0.60 | 0.51 | 0.36 | 0.73 | 0.89 | 0.89 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-09 | 19.8 | -2.36% | -8.25% | 203.7 | -4.98% |
| 2026-08 | 20.3 | -5.84% | -7.17% | 183.9 | -4.73% |
| 2026-07 | 21.5 | 0.17% | -1.54% | 163.6 | -4.42% |
| 2026-06 | 21.5 | -13.98% | -1.45% | 142.1 | -4.84% |
| 2026-05 | 25.0 | -3.35% | 5.63% | 120.6 | -5.60% |
| 2026-04 | 25.8 | -3.66% | -5.12% | 95.6 | -8.14% |
| 2026-03 | 26.8 | 43.47% | -4.70% | 69.8 | -9.22% |
| 2026-02 | 18.7 | -22.92% | -27.07% | 43.0 | -11.84% |
| 2026-01 | 24.3 | 6.64% | 5.09% | 24.3 | 5.09% |
| 2025-12 | 22.8 | 17.91% | -6.08% | 275.4 | -4.08% |
| 2025-11 | 19.3 | 1.20% | -10.18% | 252.8 | -3.86% |
| 2025-10 | 19.1 | -11.59% | -15.64% | 233.5 | -3.30% |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 61.6 | 72.3 | 69.8 | 61.0 | 65.1 | 72.5 | 76.9 | 68.3 |
| Cost of revenue | 56.2 | 64.4 | 62.0 | 54.5 | 57.7 | 64.2 | 68.2 | 61.0 |
| Gross profit | 5.4 | 7.9 | 7.8 | 6.6 | 7.3 | 8.3 | 8.7 | 7.3 |
| Operating expenses | 6.3 | 6.5 | 5.8 | 5.6 | 6.4 | 5.5 | 5.9 | 5.7 |
| Operating income | -0.9 | 1.4 | 2.0 | 1.0 | 0.9 | 2.8 | 2.7 | 1.6 |
| Non-operating items | 3.2 | 3.7 | 1.9 | 3.4 | 3.1 | -3.0 | -0.3 | 0.0 |
| Pre-tax income | 2.3 | 5.1 | 3.9 | 4.4 | 4.1 | -0.2 | 2.4 | 1.6 |
| Income tax | -0.1 | 0.0 | 0.5 | 0.5 | 0.7 | 0.1 | 0.5 | 0.5 |
| Continuing operations | 2.4 | 5.0 | 3.4 | 3.8 | 3.3 | -0.3 | 1.9 | 1.1 |
| Net income | 2.4 | 5.0 | 3.4 | 3.8 | 3.3 | -0.3 | 1.9 | 1.1 |
| Net income to parent | 2.4 | 5.0 | 3.4 | 3.8 | 3.3 | -0.3 | 1.9 | 1.1 |
| Net income to NCI | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other comprehensive income | 168.0 | 27.4 | 35.9 | 43.5 | 25.4 | -20.9 | 11.1 | -73.0 |
| Total comprehensive income | 170.4 | 32.4 | 39.2 | 47.3 | 28.7 | -21.2 | 13.0 | -71.9 |
| EPS (TWD) | 0.14 | 0.30 | 0.20 | 0.22 | 0.20 | -0.02 | 0.11 | 0.07 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 165.1 | 163.5 | 152.7 | 146.1 | 140.0 | 151.0 | 158.6 | 152.9 |
| Non-current assets | 640.2 | 479.7 | 458.7 | 425.3 | 380.0 | 357.6 | 378.4 | 370.7 |
| Total assets | 805.3 | 643.1 | 611.5 | 571.4 | 520.0 | 508.6 | 537.0 | 523.6 |
| Current liabilities | 56.4 | 62.8 | 63.5 | 53.3 | 50.4 | 67.3 | 73.9 | 59.6 |
| Non-current liabilities | 91.8 | 93.7 | 93.8 | 94.7 | 93.7 | 94.0 | 94.5 | 94.9 |
| Total liabilities | 148.2 | 156.5 | 157.3 | 148.0 | 144.0 | 161.3 | 168.4 | 154.5 |
| Share capital | 168.5 | 168.5 | 168.5 | 168.5 | 168.5 | 168.5 | 168.5 | 168.5 |
| Capital surplus | 9.6 | 9.6 | 9.6 | 9.6 | 9.5 | 9.4 | 9.5 | 9.5 |
| Retained earnings | 200.9 | 198.5 | 193.2 | 198.3 | 193.7 | 190.4 | 190.8 | 202.4 |
| Other equity | 278.3 | 110.3 | 83.2 | 47.3 | 4.5 | -20.9 | 0.0 | -11.1 |
| Treasury stock | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 |
| Equity to parent | 657.0 | 486.6 | 454.2 | 423.4 | 376.0 | 347.3 | 368.6 | 369.1 |
| Total equity | 657.0 | 486.6 | 454.2 | 423.4 | 376.0 | 347.3 | 368.6 | 369.1 |
| Book value per share (TWD) | 39.05 | 28.92 | 27.00 | 25.16 | 22.35 | 20.64 | 21.91 | 21.94 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10.0 | 10.6 | -1.2 | 2.2 | 12.4 | 7.7 | 3.3 | 5.2 |
| Investing cash flow | -0.1 | -1.5 | -3.1 | -4.1 | -2.5 | -0.5 | -1.0 | -5.0 |
| Financing cash flow | -8.7 | -2.8 | 3.1 | 1.8 | -15.0 | -5.1 | -0.4 | -6.7 |
| FX effect | 0.5 | 0.2 | 1.1 | 1.5 | 0.8 | -4.4 | 0.4 | 0.1 |
| Net change in cash | 1.8 | 6.5 | -0.1 | 1.5 | -4.4 | -2.4 | 2.3 | -6.4 |
| Cash, beginning | 32.3 | 32.3 | 32.3 | 35.2 | 35.2 | 35.2 | 35.2 | 42.4 |
| Cash, ending | 40.4 | 38.6 | 32.1 | 32.3 | 30.8 | 35.1 | 37.5 | 35.2 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 292.65% | 260.28% | — | — | — | — | — | — |
| Debt ratio | 18.41% | 24.34% | 25.72% | 25.90% | 27.70% | 31.72% | 31.36% | 29.51% |
| Equity ratio | 81.59% | 75.66% | 74.28% | 74.10% | 72.30% | 68.28% | 68.64% | 70.49% |
| Equity multiplier | 1.23 | 1.32 | 1.35 | 1.35 | 1.38 | 1.46 | 1.46 | 1.42 |
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.40 | 0.47 | 0.47 | 0.50 | 0.50 | 0.49 | 0.48 | 0.46 |
| Equity turnover | 0.51 | 0.64 | 0.65 | 0.70 | 0.69 | 0.69 | 0.67 | 0.63 |
Source: MOPS. For reference only; not investment advice.